From 19-22 February 2013, Sabin Executive Vice-President Dr. Ciro de Quadros and Program Officer Brian Shaw participated in the SEARO Regional Consultation on Measles Elimination and Rubella/CRS Control, held in Kathmandu, Nepal. As a member of the Measles Rubella Initiative (MRI), Sabin is committed to the elimination of measles, rubella & congenital rubella syndrome (CRS).
Rwanda’s measles-rubella vaccination campaign, which is being launched today, is the beginning of an effort to vaccinate more than 700 million children under 15 years of age against two disabling and deadly diseases.
A vaccine that works in newborns, pneumococcal disease burden in Latin America, the quest for a yellow fever vaccine and more
As the prominence of dengue grows, the need for an up-to-date and comprehensive understanding of the burden of disease becomes more and more important. For dengue, this means not just mortality but also morbidity; the true cost of the disease lies not just in the lives lost, but in the burden placed on health systems, the days of work missed, and other harder to calculate figures.

Pages